Role of interleukin-7 in bone and T-cell homeostasis

Immunological Reviews

Volumn 208, Issue , 2005, Pages 169-180

  Lee, Sun Kyeong ^a   Surh, Charles D ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

B LYMPHOCYTE; BONE; CELL PROLIFERATION; DNA BINDING; HOMEOSTASIS; LYMPHOCYTOPENIA; MEMORY CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SURVIVAL; T LYMPHOCYTE;

EID: 28544439090     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00339.x     Document Type: Review

References (154)

1. Henney CS. Interleukin 7: effects on early events in lymphopoiesis. Immunol Today 1989;10:170-173.
2. Namen A, et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988;333:571-573.
3. Namen A, et al. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988;167:988-1002.
4. Lee G, Namen AE, Gillis S, Kincade PW. Recombinant interleukin-7 supports the growth of normal B lymphocyte precursors. Curr Top Microbiol Immunol 1988;141:16-18.
5. Goodwin RG, et al. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989;86:302-306.
6. Sudo T, et al. Interleukin 7 production and function in stromal cell-dependent B cell development. J Exp Med 1989;170:333-338.
7. Takeda S, Gillis S, Palacios R. In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B and pro-T-lymphocyte clones and fetal thymocyte clone. Proc Natl Acad Sci USA 1989;86:1634-1638.
8. Murray R, Suda T, Wrighton N, Lee F, Zlotnik A. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol 1989;1:526-531.
9. Morrissey P, et al. Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med 1989;169:707-716.
10. Chazen G, Pereira GMB, LeGros G, Gillis S, Shevach EM. Interleukin-7 is a T-cell growth factor. Proc Natl Acad Sci USA 1989;86:5923-5927.
11. Conlon P, et al. Murine thymocytes proliferate in direct response to interleukin-7. Blood 1989;74:1368-1373.
12. Sutherland G, et al. The gene for human interleukin 7 (IL-7) is at 8q12-13. Hum Genet 1989;82:371-372.
13. Lupton S, Gimpel S, Jerzy R, Brunton LL, Hjerrild KA, Cosman D, Goodwin RG. Characterization of the human and murine IL-7 genes. J Immunol 1990;144:3592-3601.
14. Park L, Friend DJ, Schmierer AE, Dower SK, Namen AE. Murine interleukin-7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J Exp Med 1990;171:1073-1089.
15. Noguchi M, et al. Interelukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147-157.
16. Noguchi M, et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993;262:1877-1880.
17. Kondo M, et al. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 1994;263:14S3-1454.
18. Takeshita T, et al. Cloning of the gamma chain of the human IL-2 receptor. Science 1992;257:379-382.
19. Kondo M, et al. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 1993;262:1874-1877.
20. Russell S, et al. Interaction of IL-2R beta and gamma chains with Jak1 and Jak3: Implications for XSCID XCID. Science 1994;266:1042-1045.
21. Giri J, et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994;13:2822-2830.
22. Habib T, Senadheera S, Weinberg K, Kaushansky K. The common γ chain (γC) is a required signaling component of the IL-21 receptor and supports IL-21 -induced cell proliferation via JAK3. Biochemistry 2002;41:8725-8731.
23. Lai S, Molden J, Goldsmith MA, Shared γc subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. J Clin Invest 1997;99:169-177.
24. Pechon J, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994;180:1955-1960.
25. + B cells in vitro and signals via a novel mechanism. J Immunol 1999;162:677-683.
26. Al-Rawi M, Mansel RE, Jiang WG. Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signaling complex in human solid tumours. Histol Histopathol 2003;18:911-923.
27. Rajnavolgyi E, et al. IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases. Cell Signal 2002;14:761-769.
28. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995;181:1519-1526.
29. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998;20:394-397.
30. Li Y-S, Wasserman R, Hayakawa K, Hardy RR. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 1996;5:527-535.
31. Hardy R, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001;19:595-621.
32. Mojica M, et al. Phenotypic distinction and functional characterization of pro-B cells in adult mouse bone marrow. J Immunol 2001;166:3042-3051.
33. Mundy GR, Roodman GD. Osteoclast ontogeny and function. In: Peck W, ed. Bone and Mineral Research Annual. New York: Elsevier, 1987:209-279.
34. Katazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994;94:2397-2406.
35. Ishimi Y, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-3303.
36. Girasole G, Passen G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 1994;93:1516-1524.
37. Onoe Y, et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 1996;156:758-764.
38. Tamura T, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993;90:11924-11928.
39. Kincade P. Experimental models for understanding B lymphocyte formation. Adv Immunol 1987;41:181-267.
40. Borzillo G, Endo K, Tsujimoto Y. Bd-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene 1992;7:869-876.
41. Griffiths S, et al. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med 1994;179:1789-1797.
42. Borghesi L, Smithson G, Kincade PW. Stromal cell modulation of negative regulatory signals that influence apoptosis and proliferation of B lineage lymphocytes. J Immunol 1997;159:4171-4179.
43. Lu L, Osmond DG. Apoptosis during B lymphopoiesis in mouse bone marrow. J Immunol 1997;158:5136-5145.
44. Lu L, Chaudhury P, Osmond DG. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2. J Immunol 1999;162:1931-1940.
45. Baird A, Gerstein RM, Berg LJ. The role of cytokine receptor signaling in lymphocyte development. Curr Opin Immunol 1999;11:157-166.
46. Al-Shami A, et al. A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med 2004;200:159-168.
47. Khaled AR, et al. Bax deficiency partially corrects interleukin-7 receptor alpha deficiency. Immunity 2002;17:561-573.
48. -/- mice. Cell 1997;89:1011-1019.
49. Pellegrini M, Bouillet P, Robati M, Belz GT, Davey GM, Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 2004;200:1189-1195.
50. Schlissel MS, Durum SD, Muegge K. The interleukin 7 receptor is required for T cell receptor gamma locus accessibility to the V(D)J recombinase. J Exp Med 2000;191:1045-1050.
51. Muegge K, Vila MP, Durum SK. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 1993;261:93-95.
52. Chambers T, Hall TJ. Cellular and molecular mechanisms in the regulation and function of osteoclasts. Vitam Horm 1991;46:41-86.
53. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-79.
54. Roodman GD. Advances in bone biology: the osteoclast. Endocr Rev 1996;17:308-332.
55. Manabe N, et al. Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 2001;167:2625-2631.
56. Kato I, Sato H, Kudo A. TRANCE together with IL-7 induces pre-B cells to proliferate. Eur J Immunol 2003;33:334-341.
57. Era T, Nishikawa S, Sudo T, Wang FH, Ogawa M, Kunisada T, Hayashi S. How B-precursor cells are driven to cycle. Immunol Rev 1994;137:35-51.
58. Grabstein K, et al. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med 1993;178:257-264.
59. Weitzmann M, Roggia C, Toraldo G, Weitzmann L, Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002;110:1643-1650.
60. Miyaura C, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997;94:9360-9365.
61. Morrissey P, et al. Administration of IL-7 to normal mice. J Immunol 1991;147:561-568.
62. Weitzmann M, Cenci S, Rifas L, Brown C, Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 2000;96:1873-1878.
63. Toraldo G, Roggia C, Qian W-P, Pacific R, Weitzmann MN. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor KB ligand and tumor necrosis factor α from T cells. Proc Natl Acad Sci USA 2002;100:125-130.
64. Ryan M, Grassi F, Qian W, Weitzmann MN, Pacifici R. Estrogen represses hematopoietic stem cell proliferation, thymopoiesis, thymic output and T cell peripheral expansion through IL-7 [Abstract]. J Bone Miner Res 2004;19:S31.
65. Udagawa N, et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 1989;125:1805-1813.
66. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 1988;123:1504-1510.
67. Quinn J, Elliott WJ, Gillespie MT, Martin TJ. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998;139:4424-4427.
68. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997;89:1021-1031.
69. Suda T, Tanaka S, Takahashi N. Macrophage colony-stimulating factor (M-CSF) is essential for differentiation rather than proliferation of osteoclast progenitors. Osteoporos Int 1993;3:111-113.
70. Tanaka S, et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993;91:257-263.
71. Arai F, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-fms and receptor activator of nuclear factor KB (RANK) receptors. J Exp Med 1999;190:1741-1754.
72. Hofstetter W, Wetterwald A, Cecchini MG, Felix R, Fleisch H, Mueller C. Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc Natl Acad Sci USA 1992;89:9637-9641.
73. Lacey D, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
74. Yasuda H, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Nad Acad Sci USA 1998;95:3597-3602.
75. Wong B, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J Biol Chem 1997;272:25190-25194.
76. Anderson D, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-179.
77. Lee S, Lorenzo JA. Parathyroid hormone stimulated TRANCE and inhibits osteoprotegerin messenger ribonudeic acid expression in murine bone marrow cultures: correlation with osteodast-like cell formation. Endocrinology 1999;140:3552-3561.
78. Hsu H, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Nad Acad Sci USA 1999;96:3540-3545.
79. Kong Y, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-323.
80. Fata J, et al. The osteoclast differentiation factor osteoprotegerin- ligand is essential for mammary gland development. Cell 2000;103:41-50.
81. Martin T, Gillespie MT. Receptor activator of nuclear factor kappaB ligand (RANKL). another link between breast and bone. Trends Endocrinol Metab 2001;12:2-4.
82. Bhatia S, Tygrett LT, Grabstein KH, Waldschmidt TJ. The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med 1995;181:1399-1409.
83. Sudo T, et al. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci USA 1993;90:9125-9129.
84. Fraser C, Thacker JD, Hogge DE, Fatur-Saunders D, Takei F, Humphries RK. Alterations in lymphopoiesis after hematopoietic reconstitution with IL-7 virus-infected bone marrow. J Immunol 1993;151:2409-2418.
85. Mertsching E, Grawunder U, Meyer V, Rolink T, Ceredig R. Phenotypic and functional analysis of B lymphopoiesis in interleukin-7-transgenic mice: expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen. Eur J Immunol 1996;26:28-33.
86. Mertsching E, Meyer V, Linares J, Lombard-Platet S, Ceredig R. Interleukin-7, a non-redundant potent cytokine whose over-expression massively perturbs B-lymphopoiesis. Int Rev Immunol 1998;16:285-308.
87. Valenzona H, Pointer R, Ceredig R, Osmond DG. Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis. Exp Hematol 1996;24:1521-1529.
88. Fisher A, Burdet C, Bunce C, Merkenschlager M, Ceredig R. Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential, Int Immunol 1995;7:415-423.
89. Mertsching E, Burdet C, Ceredig R. IL-7 transgenic mice: analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro. Int Immunol 1995;7:401-414.
90. Ceredig R, Andersson J, Melchers F, Rolink A. Effect of deregulated IL-7 transgene expression on B lymphocyte development in mice expressing mutated pre-B cell receptors. Eur J Immunol 1999;29:2797-2807.
91. Maki K, et al. Interleukin-7 receptor-deficient mice lack γδT cells. Proc Nad Acad Sci USA 1996;93:7172-7177.
92. Rich B. Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7 deficient mice. Immunol Today 1997;92:374-380.
93. Maeurer M, Lotze MT. Interleukin-7 (IL-7) knockout mice: Implications for lymphopoiesis and organ-specific immunity. Int Rev Immunol 1998;16:309-322.
94. Wei C, Zeff R, Goldschneider I. Murine pro-B cells require IL-7 and its receptor complex to upregulate IL-7Rα, terminal deoxynucleotidyltransferase and cμ expression. J Immunol 2000;164:1961-1970.
95. Lee S, Kalinowski JF, Cabrera-Hernandez A, Adams D, Gronowicz G, Lorenzo JA. Interleukin-7 influences osteoclast and osteoblast function in vivo but is not a critical factor in ovariectomy-induced bone loss [Abstract], J Bone Miner Res 2003;18:S327.
96. Nutt S, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999;401:556-562.
97. Scott E, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU. 1 in the development of multiple hematopoietic lineages. Science 1994;265:1573-1677.
98. McKercher S, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 1996;15:5647-5658.
99. DeKoter R, Lee H-J, Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 2002;16:297-309.
100. DeKoter R, Singh H. Regulation of B lymphocytes and macrophage development by graded expression of PU. 1. Science 2000;288:1439-1441.
101. Katavic V, et al. The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone 2003;32:581-590.
102. + cells: its role in accelerated osteodastogenesis due to estrogen deficiency. J Bone Miner Res 2001;16:2215-2221.
103. Jacquin C, Lee SK, Lorenzo JA, Aguila HL. Identification of multiple osteoclast precursor populations in murine bone marrow J Bone Miner Res 2005 (in press).
104. Lee S, Kalinowski JF, Jastrzebski SL, Puddington L, Lorenzo JA. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Endocrinology 2003;144:3524-3531.
105. Menaa C, Kurihara N, Roodman GD. CFU-GM-derived cells form osteodasts at a very high efficiency. Biochem Biophys Res Commun 2000;267:943-946.
106. Lee S, Kalinowski JF, Adams DJ, Aguila HL, Lorenzo JA. Osteoblast specific overexpression of human Interleukin-7 increases femoral trabecular bone mass in female mice and inhibits in vitro osteodastogenesis [Abstract]. J Bone Miner Res 2004;19:S410.
107. Surh CD, Sprent J. Regulation of mature T cell homeostasis. Semin Immunol 2005;17:183-191.
108. + T cells survival is not direcdy linked to self-MHC-induced TCR signaling. Nat Immunol 2000;1:329-335.
109. + T cells? J Exp Med 2003;198:1089-1102.
110. Labrecque N, Whitfield LS, Obst R, Waltzinger C, Benoist C, Mathis D. How much TCR does a T cell need? Immunity 2001;15:71-82.
111. Polic B, Kunkel D, Scheffold A, Rajewsky K. How alpha beta T cells deal with induced TCR alpha ablation. Proc Nad Acad Sci USA 2001;98:8744-8749.
112. + T cells Nat Immunol 2000;1:107-111.
113. Vella A, Teague TK, Ihle J, Kappler J, Marrack P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 1997;186:325-330.
114. Boursalian TE, Bottomly K. Survival of naive CD4 T cells: roles of restricting versus selecting MHC class II and cytokine milieu. J Immunol 1999;162:3795-3801.
115. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000;1:426-432.
116. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Nad Acad Sci USA 2001;98:8732-8737.
117. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, Bradley LM. Interleukin 7 regulates die survival and generation of memory CD4 cells. J Exp Med 2003;198:1797-1806.
118. Vivien L, Benoist C, Madiis D. T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. Int Immunol 2001;13:763-768.
119. + T cells. J Exp Med 2002;195:1533-1539.
120. Geiselhart LA, Humphries CA, Gregorio TA, Mou S, Subleski J, Komschlies KL. IL-7 administration alters the CD4: CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol 2001;166:3019-3027.
121. Bell EB, Sparshott SM, Drayson MT, Ford WL. The stable and permanent expansion of functional T lymphocytes in adiymic nude rats after a single injection of mature T cells. J Immunol 1987;139:1379-1384.
122. Rocha B, Dautigny N, Pereira P. Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/8 ratios in vivo. Eur J Immunol 1989;19:905-911.
123. Ernst B, Lee D-S, Chang JM, Sprent J, Surh CD. The pepitide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 1999;11:173-181.
124. + T cells in lymphopenic hosts. Immunity 1999;11:183-190.
125. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999;286:1377-1381.
126. Viret C, Wong FS, Janeway CA Jr. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide : self-MHC complex recognition. Immunity 1999;10:559-568.
127. Ge Q, Hu H, Eisen HN, Chen J. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc Nad Acad Sci USA 2002;99:2989-2994.
128. Fry TJ, et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001;97:2983-2990.
129. Napolitano LA, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001;7:73-79.
130. + T cells in lymphopenic hosts. Immunity 1999;11:183-190.
131. Kieper WC, et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol 2005;174:3158-3163.
132. Kassiotis G, Zamoyska R, Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med 2003;197:1007-1016.
133. Kieper WC, Burghardt JT, Surh CD. A role for TCR affinity in regulating naive T cell homeostasis. J Immunol 2004;172:40-44.
134. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I Interferon in vivo. Science 1996;272:1947-1950.
135. Tough DF, Sun S, Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 1997;185:2089-2094.
136. + T cells in vivo by IL-15. Immunity 1998;8:S91-599.
137. + T cell lineages in interleukin 15-deficient mice. J Exp Med 2000;191:771-780.
138. Lodolce JP, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998;9:669-676.
139. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002;17:537-547.
140. + T cell homeostasis. J Exp Med 2004;200:825-834.
141. Sandau MM, Schluns KS, Lefrancois L, Jameson SC. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells. J Immunol 2004;173:6537-6541.
142. + T cells is dispensable for T cell memory. Proc Nad Acad Sci USA 2003;100:4724-4729.
143. + bone marrow-derived cells. Blood 2004;103:988-994.
144. + T cells. J Exp Med 2002;195:1515-1522.
145. + cells. J Exp Med 2002;195:1523-1532.
146. Becker TC, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002;195:1541-1548.
147. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002;168:4827-4831.
148. Swain SL, Hu H, Huston G. Class II-independent generation of CD4 memory T cells from effectors. Science 1999;286:1381-1383.
149. Kassiotis G, Garcia S, Simpson E, Stockinger B. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat Immunol 2002;3:244-250.
150. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003;4:680-686.
151. + T cell survival but not for antigen proliferation. Nat Immunol 2000;1:54-58.
152. + T cell memory. Proc Natl Acad Sci USA 2004;101:9357-9362.
153. + T cells with a naive phenotype in the periphery. Dev Immunol 1992;2:141-150.
154. Vos Q, Jones LA, Kruisbeek AM. Mice deprived of exogenous antigenic stimulation develop a normal repertoire of functional T cells. J Immunol 1992;149:1204-1210.